Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Prenetics' IM8 Announces Collaboration with Mayo Clinic to Develop New Line of Premium Supplements
2024-12-19 21:30
Telix Manufacturing Solutions, Brussels South Update: Cyclotron Installation Complete
2024-12-19 17:02
Pharus Diagnostics LLC Announces Validation of a Laboratory-Developed Test for Early Pancreatic Cancer Detection
2024-12-19 01:00
Neurizon Files IND Application to Support HEALEY ALS Platform Trial
2024-12-18 10:59
Amai Proteins succesfully completed world's first human clinical trial on effects of sweet proteins, with sweelin®
2024-12-17 09:00
Menarini Group announces Positive Topline Data from Pivotal Phase 3 BROADWAY & TANDEM Clinical Trials Evaluating Obicetrapib and the Fixed-Dose Combination Obicetrapib with Ezetimibe 10 mg
2024-12-16 22:08
World's 1st Stem Cell Book on Animals, Reveals How to Extend the Lives of Pets
2024-12-16 22:00
HiRO Forges Strategic Partnership with CHA University Bundang Medical Center in South Korea
2024-12-16 10:30
Innovent and Lilly Expand Collaboration Through Agreement on Commercialization Rights for Jaypirca® (pirtobrutinib) in Mainland China
2024-12-16 07:55
Alphamab Oncology Presented the Phase II Clinical Data of KN046 in Combination with Axitinib for the Treatment of Advanced NSCLC at ESMO IO Congress 2024
2024-12-13 10:35
Transcenta Debuts Promising Anti-Tumor Activity of Novel LIV-1 Targeting ADCs with Site-Specific Conjugated Topo I Inhibitor Payload in TNBC Tumor Models at 2024 SABCS
2024-12-13 08:00
Menarini Group and MEDSIR Present the Phase III Study ADELA: A New Therapeutic Strategy for Advanced Breast Cancer
2024-12-12 18:07
CBC Group R-Bridge Healthcare Fund Announces up to US$50 Million Financing for Human Investments Ltd. to Fund Motiva® Market Expansion
2024-12-12 14:14
Everest Medicines Announces the First Prescription of VELSIPITY® Issued in Macau, Officially Beginning to Benefit Asian Patients
2024-12-12 11:48
Viva Biotech Officially Establishes Boston Branch, Marking Another Milestone in Global Expansion
2024-12-11 14:44
Call for Application for 2025 Tsinghua Amgen Scholars Program
2024-12-11 14:33
2024 PHBS-CJBS Global Pitch Competition Grand Final Held
2024-12-11 12:29
Live from ASH 2024 | First Dataset of Olverembatinib as Second-Line Therapy in Patients with Non-T315I-Mutant CP-CML Presented in Oral Report
2024-12-10 21:27
Live from ASH 2024 | First Dataset of Olverembatinib in Combination with Bcl-2 Inhibitor Lisaftoclax Demonstrates Potential Clinical Benefits as a Chemotherapy-Free Regimen for Children with R/R Ph+ ALL
2024-12-10 20:48
Antengene Presents Results from Two Late-Stage Clinical Studies of Selinexor at ASH 2024
2024-12-10 08:30
1
31
32
33
34
35
264